申请人:——
公开号:US04528195A1
公开(公告)日:1985-07-09
Pharmaceutical formulations comprising an imidazole (or pharmaceutically acceptable salt thereof) of formula: ##STR1## wherein (i) A is an aliphatic hydrocarbon residue of from 1 to 4 carbon atoms and R is a naphthyl, tetrahydronaphthyl, heterocyclyl, arylthio, arylalkylthio, aryloxy, arylalkyloxy, arylhydroxymethylene, arylcarbonyl, arylalkylcarbonyl, alkyloxy, alkylthio or a substituted cycloalkyl or cycloalkenyl group or (ii) A is an --SO.sub.2 -- group and R is aryl or heterocyclyl or (iii) A is a chemical bond and R is a heterocyclyl or Some of these imidazoles and salts are novel. Methods of preparing the imidazoles are disclosed. The imidazoles and their salts are useful in the treatment or prophylaxis of thrombo-embolic conditions, shock and angina pectoris.
含有式如下的咪唑(或其药学上可接受的盐)的制剂:##STR1## 其中(i)A是1至4个碳原子的脂肪烃残基,R是萘基、四氢萘基、杂环基、芳基硫基、芳基烷硫基、芳基氧基、芳基烷氧基、芳基羟甲基、芳基羰基、芳基烷基羰基、烷氧基、烷硫基或取代的环烷基或环烯基;或(ii)A是--SO.sub.2--基团,R是芳基或杂环基;或(iii)A是化学键,R是杂环基。其中一些咪唑和盐是新颖的。公开了制备咪唑的方法。这些咪唑及其盐在治疗或预防血栓栓塞性疾病、休克和心绞痛方面有用。